UnitedHealth Group Incorporated (UNH)
Forget UnitedHealth: Two Stocks To Buy Now
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) is back in every headline, riding a 31.24% one-month bounce off a 9.38% Q1 EPS beat that had Reddit cheering a “UnitedHealth +7% premarket” rally on April 21.
UnitedHealth: Beaten Down, Not Broken
UnitedHealth Group Incorporated has surged 18% since my last update, outperforming the benchmark and reinforcing my Strong Buy rating. Despite the recent rally, I still view UNH as undervalued and well-positioned to outperform over the long term. Recent solid double-beat earnings have reignited bullish momentum and improved investor confidence in UNH's consistency.
Cardinal Health Was Supposed to Beat UnitedHealth. Did It? Will It?
Roughly a year ago, 24/7 Wall St. ran a piece titled Forget UnitedHealth.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Will UnitedHealth's New Optum Rx Model Boost PBM Pricing Transparency?
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
UnitedHealth: Watch The Recovery In Action
UnitedHealth Group is executing a robust turnaround, with Q1 2026 revenue up 2% to $111.7 billion and EPS beating consensus at $7.23. UNH's aggressive repricing, AI-driven efficiencies, and strategic exits support raised 2026 EPS guidance to at least $18.25, with double-digit growth expected through 2028. Shares trade at a forward PE of 19.3, below the 10-year average, implying a 6% discount to a $369 fair value and potential double-digit annualized returns.
UnitedHealth to remove annoying barrier for slew of medical procedures
UnitedHealth said Tuesday it is planning to slash required authorizations by nearly a third later this year – making it easier for patients to access an array of tests, surgeries and procedures.
What's Going on With UnitedHealth Stock?
UnitedHealth (UNH 0.46%) increased prices to offset the higher costs of serving customers.
Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
Goldman Sachs (NYSE:GS | GS Price Prediction) added UnitedHealth Group (NYSE:UNH) stock to its U.S.
UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?
UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.
UnitedHealth or Humana: Which Managed Care Stock Had the Healthiest Returns in April?
The April scoreboard is in for managed care. UnitedHealth Group (NYSE:UNH | UNH Price Prediction) stock and Humana (NYSE:HUM) stock both staged ferocious rallies, yet UnitedHealth won by roughly 56 basis points (bps).
